Description
Overview:
A dual-compound research formulation designed for investigation into peptide receptor activity and metabolic signaling.
Mechanism Details:
Retatrutide is a triple agonist acting on:
– GLP-1 receptor
– GIP receptor
– Glucagon receptor
Cagrilintide is an amylin analog studied for:
– Amylin receptor activity
– Appetite-regulation pathway research
– Energy balance signaling pathways
Research Focus Areas:
– Multi-receptor agonist activity
– Hormonal interaction pathways
– Metabolic signaling cascades
– Appetite regulation mechanisms

Reviews
There are no reviews yet.